As industry leaders in infection prevention, our mission is to ensure that our users are protected against the threat of emerging disease outbreaks in all of the markets we serve. In choosing Prevention as your daily disinfectant, we want to ensure you have the confidence that your clients and team are covered in the event of an outbreak as well as for everyday use.
COVID-19
Prevention One-Step Disinfectants have a US Environmental Protection Agency (EPA) approved label claim for use against SARS-CoV-2, the virus that causes COVID-19. The product has been validated by independent testing and proven efficacious against SARS-CoV-2, following a contact time of one minute. Prevention also appears on the EPA’s List N, which identifies disinfectants that are appropriate for use against SARS-CoV-2, the virus that causes COVID-19 – this can be found by searching by the product’s EPA registration number (74559-1). Prevention is expected to be effective against all variants of the virus, including SARS-CoV- 2 – Delta Strain, when used in accordance with the directions for use against SARS-CoV-2.
MONKEY POX
In cases of emerging viral pathogens such as Monkeypox Virus, when there is no test that can be conducted to validate the efficacy of a disinfectant, the EPA utilizes their Emerging Viral Pathogens Policy to determine the expected efficacy of a disinfectant against an emerging virus. In the case of an enveloped virus such as Monkeypox Virus, the following criteria are used to determine efficacy of a disinfectant upon enactment of the Emerging Viral Pathogens Policy:
1. The product must be a hospital or broad-spectrum disinfectant product registered with the EPA.
2. The product must have acceptable efficacy data previously submitted to and reviewed by the Agency against at least one non-enveloped virus, which is considered to be more resistant to disinfectants compared to enveloped viruses such as Monkeypox Virus.
The Prevention line of disinfectants (including Prevention Ready-to-Use liquid and Wipes) fulfill these criteria and therefore can be used against Monkeypox Virus on hard, non-porous surfaces as part of a facility’s infection prevention and control protocols.
